Nicholette Zeliadt manages The Transmitters’s staff reporters and interns, and she commissions and edits news articles. She joined The Transmitter as news writer in 2014. Before that, she was a freelance writer and editor. Her work has appeared in The New York Times, Scientific American, Nature Medicine, Science and The Scientist.
Nicholette Zeliadt
Managing editor
The Transmitter
From this contributor
Leaving lasting marks with Tessa Montague
Spotted around the web: INSAR; cerebellar gene expression; pangenome
Spotted around the web: Mapping histones; COVID-19 births; acetaminophen lawsuits
New diagnostic code for PTEN syndrome may spur research
Education
- Ph.D. in environmental health, University of Minnesota
- B.A. in biochemistry, University of Iowa
Fellowships
- AAAS Mass Media Fellowship
Explore more from The Transmitter
‘How to Change a Memory: One Neuroscientist’s Quest to Alter the Past,’ an excerpt
Part scientific exploration, part memoir, Steve Ramirez’s new book delves into the study of memory manipulation and his personal journey of discovery, friendship and grief.
‘How to Change a Memory: One Neuroscientist’s Quest to Alter the Past,’ an excerpt
Part scientific exploration, part memoir, Steve Ramirez’s new book delves into the study of memory manipulation and his personal journey of discovery, friendship and grief.
Journal retracts two papers evaluating ADHD interventions
Frontiers in Public Health retracted one paper for its “unacceptable level of similarity” to another paper, and the other over concerns about its “scientific validity.”
Journal retracts two papers evaluating ADHD interventions
Frontiers in Public Health retracted one paper for its “unacceptable level of similarity” to another paper, and the other over concerns about its “scientific validity.”
Constellation of studies charts brain development, offers ‘dramatic revision’
The atlases could pinpoint pathways that determine the fate of cells linked to neurodevelopmental conditions.
Constellation of studies charts brain development, offers ‘dramatic revision’
The atlases could pinpoint pathways that determine the fate of cells linked to neurodevelopmental conditions.